Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.

Sequestration of membrane cholesterol by cholesterol-binding proteins inhibits SARS-CoV-2 entry into Vero E6 cells.

Publication date: Jul 05, 2024

Membrane lipids and proteins form dynamic domains crucial for physiological and pathophysiological processes, including viral infection. Many plasma membrane proteins, residing within membrane domains enriched with cholesterol (CHOL) and sphingomyelin (SM), serve as receptors for attachment and entry of viruses into the host cell. Among these, human coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), use proteins associated with membrane domains for initial binding and internalization. We hypothesized that the interaction of lipid-binding proteins with CHOL in plasma membrane could sequestrate lipids and thus affect the efficiency of virus entry into host cells, preventing the initial steps of viral infection. We have prepared CHOL-binding proteins with high affinities for lipids in the plasma membrane of mammalian cells. Binding of the perfringolysin O domain four (D4) and its variant D4 to membrane CHOL impaired the internalization of the receptor-binding domain of the SARS-CoV-2 spike protein and the pseudovirus complemented with the SARS-CoV-2 spike protein. SARS-CoV-2 replication in Vero E6 cells was also decreased. Overall, our results demonstrate that the integrity of CHOL-rich membrane domains and the accessibility of CHOL in the membrane play an essential role in SARS-CoV-2 cell entry.

Concepts Keywords
Biochem Animals
Cholesterol Carrier Proteins
Coronaviruses Cell Membrane
D4 Chlorocebus aethiops
Efficiency Cholesterol
Cholesterol
COVID-19
Endocytosis
Humans
Membrane domains
Plasma membrane
Pore-forming proteins
Protein Binding
SARS-CoV-2
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Vero Cells
Viral infection
Virus Internalization

Semantics

Type Source Name
drug DRUGBANK Cholesterol
disease MESH viral infection
pathway REACTOME Attachment and Entry
disease VO Viruses
disease VO Severe acute respiratory syndrome coronavirus 2
disease VO efficiency
disease IDO entry into host
disease IDO replication
disease MESH COVID-19
pathway KEGG Endocytosis
disease VO Glycoprotein

Original Article

(Visited 1 times, 1 visits today)